open access

Vol 84, No 7 (2013)
ARTICLES
Get Citation

Evaluation of safety and effectiveness of pelvic organ prolapse treatment with the use of polypropylene mesh depending on mesh and application technique

Renata Banach, Beata Antosiak, Grażyna Blewniewska, Andrzej Malinowski
DOI: 10.17772/gp/1610
·
Ginekol Pol 2013;84(7).

open access

Vol 84, No 7 (2013)
ARTICLES

Abstract

Objectives: Evaluation of safety and effectiveness of POP (pelvic organ prolapse) treatment with the use of polypropylene mesh depending on type of mesh and application technique. Materials and methods: We carried out a retrospective study and compared the frequency of perioperative complications and treatment results three months after the surgical procedure in two groups of patients, divided according to POP type. The first group comprise of patients with anterior compartment disorders who had Prolift Anterior (n=100) or Pelvimesh Anterior (n=98) placed. The second group included patients with posterior and central compartment who had Prolifit Posterior (n=72) and Pelvimesh Posterior (n=89) fitted. Early peri- and postoperative complications criteria were: profuse intraoperative bleeding (hemoglobin decrease of 3g%), intraoperative damage of urinary bladder and bowel, presence of hematoma in paravesical and perirectal space, urine retention after miction on the second day after the operation (>100ml), uroschesis after catheter removal, early operative failure (during 3 months after the operation), mesh erosion. Results: No statistically significant differences in peri- and postoperative complications were reported between the studied groups (Pelvimesh vs. Prolift). No damage of urinary bladder or bowel was found in any of the studied groups. Other complications in Prolift Ant. Vs. Pelvimesh Ant groups were: postoperative anemia (4.00% vs. 4.09%); presence of hematoma (1.00% vs. 1.03%); postoperative urine retention (7.00% vs. 5.11%); uroschesis (1.00% vs. 1.03%); mesh erosion (2.00% vs. 1.03%); early operative failure (1.00% vs. 3.07%). Early postoperative results did not statistically differ between the Pelvimesh and the Prolift group. Results in the Prolift Post. vs. Pelvimesh Post. Groups were: postoperative anemia (2.78% vs. 5.62%); mesh erosion (1.38% vs. 0%), early operative failure (1.38% vs. 5.62%). Damage to bowel and hematoma was not observed in these groups. Conclusions: Our research failed to observe an advantage of any of the ready POP treatment kits. Despite application of different systems for mesh placement and pulling the arms through ligaments (either obturator foramen or sacrospinous ligament), no statistically significant differences were demonstrated with regard to the occurrence of early peri- and postoperative complications or efficiency in POP treatment in Prolift Anterior vs. Pelvimesh Anterior and Prolift Posterior vs. Prolift Pelvimesh groups.

Abstract

Objectives: Evaluation of safety and effectiveness of POP (pelvic organ prolapse) treatment with the use of polypropylene mesh depending on type of mesh and application technique. Materials and methods: We carried out a retrospective study and compared the frequency of perioperative complications and treatment results three months after the surgical procedure in two groups of patients, divided according to POP type. The first group comprise of patients with anterior compartment disorders who had Prolift Anterior (n=100) or Pelvimesh Anterior (n=98) placed. The second group included patients with posterior and central compartment who had Prolifit Posterior (n=72) and Pelvimesh Posterior (n=89) fitted. Early peri- and postoperative complications criteria were: profuse intraoperative bleeding (hemoglobin decrease of 3g%), intraoperative damage of urinary bladder and bowel, presence of hematoma in paravesical and perirectal space, urine retention after miction on the second day after the operation (>100ml), uroschesis after catheter removal, early operative failure (during 3 months after the operation), mesh erosion. Results: No statistically significant differences in peri- and postoperative complications were reported between the studied groups (Pelvimesh vs. Prolift). No damage of urinary bladder or bowel was found in any of the studied groups. Other complications in Prolift Ant. Vs. Pelvimesh Ant groups were: postoperative anemia (4.00% vs. 4.09%); presence of hematoma (1.00% vs. 1.03%); postoperative urine retention (7.00% vs. 5.11%); uroschesis (1.00% vs. 1.03%); mesh erosion (2.00% vs. 1.03%); early operative failure (1.00% vs. 3.07%). Early postoperative results did not statistically differ between the Pelvimesh and the Prolift group. Results in the Prolift Post. vs. Pelvimesh Post. Groups were: postoperative anemia (2.78% vs. 5.62%); mesh erosion (1.38% vs. 0%), early operative failure (1.38% vs. 5.62%). Damage to bowel and hematoma was not observed in these groups. Conclusions: Our research failed to observe an advantage of any of the ready POP treatment kits. Despite application of different systems for mesh placement and pulling the arms through ligaments (either obturator foramen or sacrospinous ligament), no statistically significant differences were demonstrated with regard to the occurrence of early peri- and postoperative complications or efficiency in POP treatment in Prolift Anterior vs. Pelvimesh Anterior and Prolift Posterior vs. Prolift Pelvimesh groups.
Get Citation

Keywords

Pelvimesh, polypropylene mesh, Pelvic organ prolapse, Prolift

About this article
Title

Evaluation of safety and effectiveness of pelvic organ prolapse treatment with the use of polypropylene mesh depending on mesh and application technique

Journal

Ginekologia Polska

Issue

Vol 84, No 7 (2013)

DOI

10.17772/gp/1610

Bibliographic record

Ginekol Pol 2013;84(7).

Keywords

Pelvimesh
polypropylene mesh
Pelvic organ prolapse
Prolift

Authors

Renata Banach
Beata Antosiak
Grażyna Blewniewska
Andrzej Malinowski

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl